Rare diseases
Investigational molecules
Locations
Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer
NorwayStudy of Drug Combination for Advanced Cancer Patients with Known Molecular Profile - FINPROVE Study
FinlandStudy on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma
The NetherlandsContinued Cancer Treatment Study with Abiraterone, Ipatasertib, Tiragolumab, and Drug Combination for Patients from Previous Genentech/Roche Trials
BelgiumStudy Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases
CroatiaStudy of Entrectinib in Children and Adolescents with Advanced or Metastatic Solid Tumors or Primary CNS Tumors with No Satisfactory Treatment Options
FranceStudy of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes
FranceStudy on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
